PRTC.L - PureTech Health Plc

Exchange: XLON

PRTC.L - PureTech Health Plc

Exchange: XLON

Wed 17'th Oct 2018

PERIOD 2018-07-18 - 2018-10-17
CHANGE -0.29%
PRICE £171.50





Request Prediction

PureTech Health Plc Stock Analysis

Technical stock analysis for Wed 17'th Oct 2018

Buy candidate since 2018-10-12 Gain 6.52%

PureTech Health Plc fell by -0.29% in the last day from £172.00 to £171.50 The price has been going up and down for this period, and there has been a 4.1% gain for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -96 920 shares and in total 62 101 shares bought and sold for approximately £10.65 million.


PureTech Health Plc lies in the upper part of a wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at £174.81 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 10.34% during the next 3 months and, with 90% probability hold a price between £167.86 and £192.89 at the end of this period.

Click here for today's Top 5 Trending Companies


PureTech Health Plc holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at £165.75 and £161.36. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday October 16, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

A buy signal from a double bottom formation was found on Friday October 12, 2018 with a target of £170.46. Despite the objective of the signal formation has been reached the stock may continue to perform well.

Relative Strength Index (RSI)

RSI14 is 61 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at £160.00 and £157.00.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, PureTech Health Plc finds support just below today's level at £160.00. If this is broken, then the next support from accumulated volume will be at £157.00 and £140.00.

Support: £160.00 Price: £171.50 Resistance: £172.00


This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved £8.50 (5.09%) between high and low. For the last week, the stock has had a daily average volatility of 5.19%.

Our recommended stoploss: £164.47 (-4.10%) (This stock has low daily movements and this gives low risk. There is a sell signal from pivot top found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Strong Buy Candidate to a Buy Candidate.

Buy Candidate

Click for Top 5 Buy Candidates

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with